These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16177573)

  • 1. p16INK4a as a second effector of the telomere damage pathway.
    Jacobs JJ; de Lange T
    Cell Cycle; 2005 Oct; 4(10):1364-8. PubMed ID: 16177573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant role for p16INK4a in p53-independent telomere-directed senescence.
    Jacobs JJ; de Lange T
    Curr Biol; 2004 Dec; 14(24):2302-8. PubMed ID: 15620660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression.
    Ohtani N; Yamakoshi K; Takahashi A; Hara E
    J Med Invest; 2004 Aug; 51(3-4):146-53. PubMed ID: 15460900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different telomere damage signaling pathways in human and mouse cells.
    Smogorzewska A; de Lange T
    EMBO J; 2002 Aug; 21(16):4338-48. PubMed ID: 12169636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).
    Herbig U; Jobling WA; Chen BP; Chen DJ; Sedivy JM
    Mol Cell; 2004 May; 14(4):501-13. PubMed ID: 15149599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.
    Wang Y; Sharpless N; Chang S
    J Clin Invest; 2013 Oct; 123(10):4489-501. PubMed ID: 24091330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes involved in the control of cellular proliferative potential.
    Reddel RR
    Ann N Y Acad Sci; 1998 Nov; 854():8-19. PubMed ID: 9928415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.
    Fordyce C; Fessenden T; Pickering C; Jung J; Singla V; Berman H; Tlsty T
    Cancer Prev Res (Phila); 2010 Feb; 3(2):190-201. PubMed ID: 20028875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress.
    Domínguez D; Feijoo P; Bernal A; Ercilla A; Agell N; Genescà A; Tusell L
    Oncotarget; 2015 Sep; 6(29):28238-56. PubMed ID: 26318587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion.
    Celli GB; de Lange T
    Nat Cell Biol; 2005 Jul; 7(7):712-8. PubMed ID: 15968270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
    Roake CM; Artandi SE
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28289249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms.
    Davis T; Singhrao SK; Wyllie FS; Haughton MF; Smith PJ; Wiltshire M; Wynford-Thomas D; Jones CJ; Faragher RG; Kipling D
    J Cell Sci; 2003 Apr; 116(Pt 7):1349-57. PubMed ID: 12615976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bypass of telomere-dependent replicative senescence (M1) upon overexpression of Cdk4 in normal human epithelial cells.
    Ramirez RD; Herbert BS; Vaughan MB; Zou Y; Gandia K; Morales CP; Wright WE; Shay JW
    Oncogene; 2003 Jan; 22(3):433-44. PubMed ID: 12545164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell death during crisis is mediated by mitotic telomere deprotection.
    Hayashi MT; Cesare AJ; Rivera T; Karlseder J
    Nature; 2015 Jun; 522(7557):492-6. PubMed ID: 26108857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
    Denchi EL; de Lange T
    Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomeres-structure, function, and regulation.
    Lu W; Zhang Y; Liu D; Songyang Z; Wan M
    Exp Cell Res; 2013 Jan; 319(2):133-41. PubMed ID: 23006819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence and immortalization of human cells.
    Duncan EL; Wadhwa R; Kaul SC
    Biogerontology; 2000; 1(2):103-21. PubMed ID: 11707927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle arrest in replicative senescence is not an immediate consequence of telomere dysfunction.
    Nassrally MS; Lau A; Wise K; John N; Kotecha S; Lee KL; Brooks RF
    Mech Ageing Dev; 2019 Apr; 179():11-22. PubMed ID: 30710559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
    Vaziri H; Benchimol S
    Oncogene; 1999 Dec; 18(53):7676-80. PubMed ID: 10618707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of growth arrest in senescence: telomere damage is not the end of the story.
    Herbig U; Sedivy JM
    Mech Ageing Dev; 2006 Jan; 127(1):16-24. PubMed ID: 16229875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.